Health Care
More on Health Care
| Washington, D.C. (Nov. 25, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, invited Craig Landau, the President and CEO of Purdue Pharma L.P., and four members of the Sackler family to testify at a hearing next month on their role in fueling the opioid epidemic. |
Washington, D.C. (Oct. 27, 2020)— Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. Mark DeSaulnier released documents obtained by the Committee as part of its investigation into Purdue Pharma and members of the Sackler family, who have owned a controlling share of Purdue since 1952.
WASHINGTON, DC – Yesterday, Chairman Raja Krishnamoorthi (D-IL) of the Oversight Subcommittee on Economic and Consumer Policy and Chairwoman Rosa DeLauro (D-CT) of the House Appropriations Subcommittee on Labor, Health and Human Services, and Education joined with Committee on Oversight and Reform Chairwoman Carolyn B. Maloney (D-NY), and Whip James E.
| Washington, D.C. (Oct. 1, 2020)—Today, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent document requests to two companies, Atlas Research and DD&T Group, regarding their work on a coronavirus advertising campaign under contracts with the Department of Health and Human Services (HHS). |
Washington, D.C. (Oct. 1, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, released three new staff reports in addition to two staff reports released yesterday as part of the Committee's landmark back-to-back hearings this week with drug company CEOs on the skyrocketing prices of prescription drugs.
Washington, D.C. (Sept. 30, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent a letter to Committee Members announcing that she is beginning to release a series of new staff reports detailing the findings of the Committee's sweeping investigation into the skyrocketing prices of prescription drugs.
Washington, D.C. (Sept. 14, 2020)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, issued the following statement in response to Assistant to the President and Director of Trade and Manufacturing Policy Peter Navarro refusing to testify before the Subcommittee about his role in the Trump Administration's now-canceled contract with Philips Respironics that would have squandered up to $504 million in taxpayer funds if the Subcommittee had not intervened: